Physician profile
Jason Wolfe
NPI 1184172314
$2,849.39
in general payments reported to CMS, 2019-2025
36 companies · $924 in 2025
The $924 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $469 · 2022: $429 · 2023: $566 · 2024: $462 · 2025: $924.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,952.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,951.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $362.51 | 2021-2025 | |
| Lilly USA, LLC | $282.05 | 2021-2025 | Mounjaro, Zepbound, Kisunla |
| Gilead Sciences, INC. | $193.45 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $173.53 | 2021-2023 | Trintellix |
| Novo Nordisk INC | $168.69 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Amgen INC. | $162.07 | 2021-2025 | Repatha, Otezla, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $156.11 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $130.43 | 2023-2025 | Farxiga, Airsupra |
| Pfizer INC. | $118.30 | 2022-2025 | |
| Glaxosmithkline, LLC. | $99.97 | 2021-2025 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.66 | 2021-2024 | Jardiance, Synjardy, Tradjenta |
| Novartis Pharmaceuticals Corporation | $97.40 | 2022-2024 | |
| Cleerly, INC. | $90.80 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Axsome Therapeutics, INC. | $79.64 | 2023-2025 | Auvelity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $70.48 | 2023-2025 | Xifaxan |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Wolfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.